Hims & Hers plummets 16% after first-quarter loss, weak earnings guidance
RSS SUMMARY · AGGREGATED FROM CNBC
Hims & Hers reached a deal with Novo Nordisk in March to sell its GLP-1 weight loss drug Wegovy on its platform.
Hims & Hers reached a deal with Novo Nordisk in March to sell its GLP-1 weight loss drug Wegovy on its platform.
Hims & Hers reached a deal with Novo Nordisk in March to sell its GLP-1 weight loss drug Wegovy on its platform.
Continue Reading
The full story continues on CNBC.
Story Sentry shows a short summary aggregated via RSS. The complete article — original photography, charts, and reporting — lives with the publisher.
The Source
CNBC
US
Analysis: Iran war hangs over Trump’s China trip — and his presidency
CNBC·1h ago·3 min read
Business
Consumer prices rose 3.8% annually in April, the highest since May 2023
CNBC·1h ago·3 min read
US
EBay rejects GameStop’s $56 billion takeover bid, calling it ‘neither credible nor attractive’
CNBC·2h ago·3 min read
US
Amazon accelerates delivery race with 30-minute dropoffs in dozens of U.S. cities
CNBC·4h ago·3 min read
Related
On this beat
US
Huge plumes of smoke rise over Florida as Everglades wildfire rages – video
THE GUARDIAN·48m ago·3 min read
US
Crews battle South Florida wildfires that have burned thousands of acres
ABC NEWS·45m ago·3 min read
US
Jake Paul admits broken jaw from Anthony Joshua fight may have ended boxing career
THE GUARDIAN·59m ago·3 min read
US
1-800-Trump-Scammed-Us
THE BULWARK·49m ago·3 min read